The biology of metastasis to a sanctuary site

被引:114
作者
Palmieri, Diane
Chambers, Ann F.
Felding-Habermann, Brunhilde
Huang, Suyun
Steeg, Patricia S.
机构
[1] NCI, Mol Therapeut Program, Ctr Canc Res, Lab Mol Pharmacol,Womens Canc Sect, Bethesda, MD 20892 USA
[2] Univ Western Ontario, Dept Oncol, London, ON, Canada
[3] Univ Western Ontario, Dept Pathol, London, ON, Canada
[4] Univ Western Ontario, Dept Med Biophys, London, ON, Canada
[5] London Reg Canc Program, London, ON, Canada
[6] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
[7] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
关键词
D O I
10.1158/1078-0432.CCR-06-2659
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis to the brain is prevalent in solid tumors and lymphomas, and is associated with shortened survival. The brain is regarded as a sanctuary site for metastatic tumor cells where they exist partially protected from drugs by the blood-tumor barrier. Model systems for brain metastasis have been developed and are now yielding mechanistic insights into the roles of angiogenesis, energy metabolism, the Her-2 and Stat3 signaling pathways, and dormancy. Specific, new approaches to combat brain metastatic disease are needed.
引用
收藏
页码:1656 / 1662
页数:7
相关论文
共 74 条
[1]   Targeting of melanoma brain metastases using engineered neural stem/progenitor cells [J].
Aboody, KS ;
Najbauer, J ;
Schmidt, NO ;
Yang, W ;
Wu, JK ;
Zhuge, Y ;
Przylecki, W ;
Carroll, R ;
Black, PM ;
Perides, G .
NEURO-ONCOLOGY, 2006, 8 (02) :119-126
[2]   Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model - an MRI study [J].
Abramovitch, R ;
Itzik, A ;
Harel, H ;
Nagler, A ;
Vlodavsky, I ;
Siegal, T .
NEOPLASIA, 2004, 6 (05) :480-489
[3]  
[Anonymous], 1978, ADV NEUROL
[4]   Pathology-based substrate for target definition in radiosurgery of brain metastases [J].
Baumert, Brigitta G. ;
Rutten, Isabelle ;
Dehing-Oberije, Cary ;
Twijnstra, Albert ;
Dirx, Miranda J. M. ;
Debougnoux-Huppertz, Ria M. T. L. ;
Lambin, Philippe ;
Kubat, Bela .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :187-194
[5]   Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].
Bendell, JC ;
Domchek, SM ;
Burstein, HJ ;
Harris, L ;
Younger, J ;
Kuter, I ;
Bunnell, C ;
Rue, M ;
Gelman, R ;
Winer, E .
CANCER, 2003, 97 (12) :2972-2977
[6]   VEGF inhibitors in cancer therapy [J].
Cardones, AR ;
Bañez, LL .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) :387-394
[7]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[8]  
CHEN E, IN PRESS CANC RES
[9]   Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].
Clayton, AJ ;
Danson, S ;
Jolly, S ;
Ryder, WDJ ;
Burt, PA ;
Stewart, AL ;
Wilkinson, PM ;
Welch, RS ;
Magee, B ;
Wilson, G ;
Howell, A ;
Wardley, AM .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643
[10]   Rodent models of brain metastasis in melanoma [J].
Cranmer, LD ;
Trevor, KT ;
Bandlamuri, S ;
Hersh, EM .
MELANOMA RESEARCH, 2005, 15 (05) :325-356